Full-Time

Sr. Scientist

Drug Product Analytics

Updated on 4/25/2024

Vaxcyte

Vaxcyte

201-500 employees

Develops broad-spectrum pneumococcal conjugate vaccines

Biotechnology

Senior

San Carlos, CA, USA

Required Skills
Communications
Data Analysis
Requirements
  • BSc or MSc in Pharmaceutics, Chemistry, Biophysics, or Biochemistry preferred
  • Strong experience in method development for immunoaffinity and multiplex immunoaffinity based assays
  • Experience in particle light scattering analysis and HPLC based assays
  • Demonstrated experience in authoring analytical technical documents
  • Participated in method transfers to external vendors and internal collaborators
  • Managerial experience is beneficial
  • High flexibility and organizational skills
  • Strong interpersonal and communication skills
  • Detail-oriented with excellent record-keeping skills
Responsibilities
  • Leading analytical method development and execution for Drug Product characterization
  • Evaluating and developing appropriate biochemical and biophysical characterization tools
  • Supporting formulation selection and stability analysis
  • Applying biophysical characterization techniques to understand antigen/adjuvant interactions
  • Managing a team of 3-4 scientists
  • Working independently to develop analytical methods and perform data review
  • Authoring protocols and reports
  • Coordinating and overseeing assay transfer with QC team and external partners

Vaxcyte is dedicated to developing a range of high-fidelity, broad-spectrum vaccines, including VAX-24, a 24-valent pneumococcal conjugate vaccine. Leveraging advanced chemistry and the proprietary XpressCF™ cell-free protein synthesis platform, the company stands out in the biotechnology field for its targeted approach to combating serious bacterial infections. This focus on cutting-edge technology and a strong pipeline of innovative vaccine candidates makes it an exciting workplace for professionals passionate about impacting global health through scientific breakthroughs.

Company Stage

IPO

Total Funding

$2.3B

Headquarters

San Carlos, California

Founded

2013

Growth & Insights
Headcount

6 month growth

25%

1 year growth

60%

2 year growth

150%